When GLP-1 Isn't Right for You: What Your Doctor Might Recommend Instead

GLP-1 medications have dominated the weight loss conversation, but they're not the right fit for everyone. Some patients have medical contraindications. Others can't tolerate the side effects. Some don't meet the clinical criteria, and some simply can't afford them. If you're in any of these situations, you still have effective options — and knowing what they are puts you in a stronger position to work with your doctor on a plan that actually works for you.

Who Shouldn't Take GLP-1 Medications?

GLP-1 medications carry absolute contraindications — conditions where the medication should never be used. These include a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), known serious hypersensitivity to semaglutide or tirzepatide, and pregnancy (these medications may cause fetal harm).

Several other conditions require careful evaluation and may make GLP-1 therapy inappropriate for you: a history of pancreatitis, active gallbladder disease, severe gastroparesis or GI motility disorders, advanced kidney disease with significant dehydration risk, or a history of severe psychiatric conditions where the medication hasn't been adequately studied.

Beyond medical contraindications, some patients simply don't respond well. Persistent, severe nausea that doesn't improve with titration adjustments, inability to maintain adequate nutrition on the medication, or psychological distress related to the treatment are all valid reasons to explore alternatives.

The Alternatives, Honestly Evaluated

Metformin (Off-Label for Weight Loss)

Prescription · ~$10–30/month generic · Insurance-friendly

Originally developed for type 2 diabetes, metformin produces modest weight loss (typically 3–5% of body weight) and has a decades-long safety track record. It's inexpensive, widely available, and often the first medication doctors reach for when GLP-1s aren't an option. It works by reducing hepatic glucose output and improving insulin sensitivity.

Metformin won't produce the dramatic results of GLP-1 medications, but for patients with prediabetes or insulin resistance, it addresses the metabolic root of weight gain rather than just suppressing appetite.

Strengths: Very affordable, well-studied safety profile, addresses insulin resistance, can be combined with other approaches

Limitations: Modest weight loss, GI side effects (diarrhea, nausea), requires periodic kidney function monitoring

Naltrexone-Bupropion (Contrave)

Prescription · ~$100–500/month · Prior auth often required

Contrave combines two existing medications: naltrexone (an opioid antagonist used in addiction medicine) and bupropion (an antidepressant). Together, they target the reward and appetite centers of the brain. Average weight loss in clinical trials was approximately 5–8% of body weight.

Contrave is particularly worth considering for patients who have significant emotional eating patterns or food-related reward-seeking behaviors, since the naltrexone component specifically dampens the "reward" signal from food. It's also appropriate for patients who could benefit from the antidepressant effects of bupropion alongside weight management.

Strengths: Oral (no injections), targets reward-driven eating, antidepressant benefit, relatively affordable

Limitations: Contraindicated with seizure history or eating disorders, can increase blood pressure, may cause insomnia

Phentermine (Adipex-P, Lomaira)

Prescription · ~$20–75/month · Short-term use (12 weeks)

Phentermine is a sympathomimetic amine that suppresses appetite by stimulating norepinephrine release. It's the oldest FDA-approved weight loss medication still in widespread use and remains one of the most commonly prescribed. Weight loss averages 5–8% of body weight over short-term use.

The main limitation is its approval for short-term use only (typically 12 weeks), though some physicians prescribe it for longer periods off-label. It's a stimulant, so it's not appropriate for patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, or a history of substance use disorders.

Strengths: Very affordable, strong appetite suppression, fast onset of action, oral medication

Limitations: Short-term only, stimulant side effects (insomnia, dry mouth, increased heart rate), contraindicated with heart disease or hypertension

Bariatric Surgery

Surgical · $15,000–35,000 (often covered by insurance) · Permanent

For patients with BMI ≥ 40 (or BMI ≥ 35 with comorbidities), bariatric surgery remains the most effective long-term weight loss intervention available. Roux-en-Y gastric bypass and sleeve gastrectomy produce average weight loss of 25–35% of body weight — substantially more than any medication.

Surgery isn't an easy path. It requires lifelong dietary modifications, vitamin supplementation, and regular follow-up. But for patients with severe obesity and significant comorbidities, the data on long-term outcomes — including resolution of type 2 diabetes, improvement in cardiovascular risk, and mortality reduction — is compelling.

Strengths: Most effective weight loss intervention, high rates of comorbidity resolution, long-term outcomes, often insurance-covered

Limitations: Surgical risks, lifelong dietary changes, vitamin deficiency risk, irreversible (most procedures), requires 3–6 month pre-surgery program

Intensive Lifestyle Intervention Programs

Various · $0–500/month · Insurance coverage varies

Structured programs that combine dietary counseling, exercise programming, and behavioral therapy can produce meaningful weight loss — typically 5–10% of body weight when properly structured and sustained. The Diabetes Prevention Program (DPP), available through many health systems and covered by Medicare, demonstrated that intensive lifestyle intervention can be as effective as metformin for preventing type 2 diabetes progression.

These programs work best for patients who have specific behavioral patterns driving their weight (emotional eating, portion distortion, sedentary habits) and who are motivated to make sustained lifestyle changes. They're also complementary to other treatments — many patients combine lifestyle programs with medication or use them as the "structured program" required for insurance prior authorization.

Strengths: No medication side effects, builds sustainable habits, improves overall health beyond weight, some programs are free or low-cost

Limitations: Requires sustained effort and commitment, slower results, high attrition rates, effectiveness varies widely by program quality

Combinations That Work

These alternatives aren't mutually exclusive. Many patients achieve their best results through strategic combinations: metformin plus a structured lifestyle program, phentermine for short-term momentum followed by behavioral maintenance, or a lifestyle program that qualifies you for insurance coverage of a GLP-1 medication down the road.

The right combination depends on your specific situation — your medical history, your budget, your insurance coverage, and what you've already tried. This is exactly the kind of conversation that benefits from a knowledgeable provider who can evaluate all your options systematically.

Not Sure What's Right for You?

A clinical evaluation can help determine which treatment approach — or combination of approaches — makes the most sense for your specific situation.

Find a Provider →

The Bigger Picture

If GLP-1 medications aren't right for you, that's not a failure — it's clinical reality. These medications are powerful tools, but they're not the only tools. The landscape of obesity treatment has more options than ever before, and the right approach for you is the one that's medically appropriate, financially sustainable, and something you can maintain long-term.

Talk to your doctor about what you've tried, what your concerns are, and what matters most to you in a treatment plan. An honest conversation about your full range of options is more valuable than any single medication.